ENDONOVO THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of 15.60% for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2023-04-17
- ENDONOVO THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was 15.60%, a 1460.00% increase from fiscal 2021.
- ENDONOVO THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2021 was 1.00%, a 93.33% decline from fiscal 2020.
- ENDONOVO THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2020 was 15.00%, a 0.00% change from fiscal 2019.
- ENDONOVO THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2019 was 15.00%, a 114.29% increase from fiscal 2018.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|
| 2022-12-31 | 15.60% 10-K · filed 2023-04-17 |
| 2021-12-31 | 1.00% 10-K · filed 2023-04-17 |
| 2020-12-31 | 15.00% 10-K · filed 2022-04-14 |
| 2019-12-31 | 15.00% 10-K · filed 2021-04-13 |
| 2018-12-31 | 7.00% 10-K · filed 2020-05-04 |